Afya (NASDAQ:AFYA) Price Target Cut to $21.00 by Analysts at JPMorgan Chase & Co.

Afya (NASDAQ:AFYA) had its price target reduced by stock analysts at JPMorgan Chase & Co. from $21.50 to $21.00 in a report released on Monday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 49.05% from the stock’s current price.

A number of other brokerages have also weighed in on AFYA. Wall Street Zen lowered shares of Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 2nd. Bank of America restated a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a report on Monday, April 20th. Finally, Zacks Research cut Afya from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 6th. One investment analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $17.10.

Afya Price Performance

AFYA opened at $14.09 on Monday. The stock has a market capitalization of $1.32 billion, a P/E ratio of 9.23, a PEG ratio of 1.44 and a beta of 0.34. Afya has a 12-month low of $13.00 and a 12-month high of $18.16. The stock has a 50-day moving average price of $14.43 and a 200-day moving average price of $14.54. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.42.

Insider Activity at Afya

In other Afya news, VP Lelio De Souza Junior sold 16,279 shares of the firm’s stock in a transaction dated Thursday, April 9th. The stock was sold at an average price of $14.53, for a total value of $236,533.87. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Santos Welder Ferreira sold 3,325 shares of Afya stock in a transaction that occurred on Friday, April 17th. The stock was sold at an average price of $15.90, for a total transaction of $52,867.50. Following the completion of the sale, the insider owned 35,000 shares of the company’s stock, valued at $556,500. This trade represents a 8.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 123,547 shares of company stock valued at $1,854,920 over the last 90 days.

Institutional Trading of Afya

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. raised its stake in shares of Afya by 167.3% in the first quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after purchasing an additional 28,226 shares during the last quarter. Geode Capital Management LLC raised its position in Afya by 85.1% during the 2nd quarter. Geode Capital Management LLC now owns 52,111 shares of the company’s stock worth $931,000 after buying an additional 23,961 shares during the last quarter. Quantbot Technologies LP acquired a new position in Afya during the second quarter valued at $117,000. Arrowstreet Capital Limited Partnership lifted its position in Afya by 5.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock valued at $1,217,000 after purchasing an additional 3,626 shares during the period. Finally, Marshall Wace LLP purchased a new stake in Afya in the second quarter valued at $249,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.